IP6K1重新连接LKB1信号,以调解高血糖内皮衰老
Changchang Xing1, Linhui Shi2, Limei Zhu3
1Institute for Developmental and Regenerative Cardiovascular Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
高血糖通过改变蛋白质通路导致血管细胞衰老. 伊诺西六酸激酶1 (IP6K1) 在这个过程中起着关键作用,影响心血管疾病的风险.
科学领域:
- 心血管生物学 心血管生物学
- 疾病的分子机制.
- 内皮细胞生物学 内皮细胞生物学
背景情况:
- 糖尿病是心血管疾病的重要危险因素.
- 内皮功能障碍是糖尿病心血管并发症的关键因素.
- 将高血糖与内皮功能障碍联系在一起的精确分子机制仍然不完全理解.
研究的目的:
- 阐明伊诺西六酸激酶1 (IP6K1) 在高血糖引起的内皮功能障碍中的作用.
- 研究IP6K1如何在高血糖条件下的内皮细胞中影响关键信号通路,包括AMPK和p53.
- 确定针对糖尿病相关心血管并发症的IP6K1的治疗潜力.
主要方法:
- 利用高血糖和内皮细胞的细胞培养模型.
- 研究了IP6K1,肝激酶B1 (LKB1),AMP激活蛋白激酶 (AMPK) 和p53.3之间的相互作用.
- 在临床前模型中使用基因操纵 (细胞特异性删除和IP6K1的过度表达).
主要成果:
- 过高血糖性高调节内皮细胞中的IP6K1表达.
- IP6K1通过抑制其降解来稳定LKB1,同时抑制LKB1对AMPK的激活.
- 升高的LKB1优先结合并激活p53,导致内皮衰老.
- IP6K1的内皮特异性除改善了高血糖引起的内皮衰老,而过度表达加剧了它.
结论:
- IP6K1充当高血糖引起的内皮衰老的关键调解者.
- IP6K1-LKB1-p53轴代表了一种新的途径,有助于糖尿病心血管并发症.
- 向IP6K1可能提供一种治疗策略,用于预防或治疗糖尿病中的内皮功能障碍.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
09:31Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets
Published on: June 25, 2012
相关概念视频
Insulin: The Receptor and Signaling Pathways
PI3K/mTOR/AKT Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
